Monday, September 23, 2019

Zydus Cadila gets EIR from USFDA for Ankleshwar facility

The company's active pharmaceutical ingredient (API) manufacturing
facility located at Ankleshwar (unit 1), Gujarat has received an
Establishment Inspection Report (EIR).

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-eir-from-usfda-for-ankleshwar-facility/articleshow/71255772.cms

No comments:

Post a Comment